Polymorphonuclear neutrophils (PMNs) play a critical role in host defense against infection and in the resolution of inflammation. However, immune responses mediated by PMN must be tightly 
functions. This suppression of PMN activation serves to facilitate host protection from pathogens while avoiding bystander tissue damage and, as such is of critical importance for a successful immune response.
Therefore, this mini-review highlights the regulation of PMN behavior through negative regulation of immune signaling pathways.
NEGATIVE REGULATION OF PMN GRANULOPOIESIS
The production and maturation of PMN (granulopoiesis) occur in the bone marrow (BM) through sequential differentiation of hematopoietic stem cells to myeloblast, promyelocytes, myelocytes, metamyelocytes, band cells, and finally mature PMN. At the end of this process, PMN leaves the BM and begin circulating in the vasculature. 5 Granulocyte CSF (G-CSF) is the major cytokine that induces granulopoiesis.
However, G-CSF binding to its receptor G-CSFR also recruits several cytoplasmic tyrosine kinases, including members of the Src family kinases that function to negatively regulate PMN release from the BM. As such, triple knockout (KO) mice lacking Hck, Lyn, and Fgr, the major Src kinases expressed in myeloid cells, have an increased proliferative response to G-CSF and more circulating PMN as compared with wild-type (WT) mice. 6 The analysis of individual roles for Hck and Lyn revealed that Hck negatively regulates G-CSF-induced proliferation of granulocytic precursors, whereas Lyn negatively regulates the production of myeloid progenitors. 6 It has also been described that the suppressor of cytokine signaling-3 (SOCS3) inhibits G-CSFR signaling by a classical negative feedback loop mechanism. Activation of G-CSFR results in recruitment of SOCS3, which binds directly to tyrosine Y729 on G-CSFR inhibiting JAK/STAT3 activation and thus regulating G-CSF-mediated PMN proliferation. 7 In addition to inhibiting G-CSFR signaling, SOCS3 also inhibits IL-6 signaling by binding the signal transducing receptor subunit gp130, a receptor that is closely related to G-CSFR. 7 Boyle et al. 8 showed that mice expressing a truncated SOCS3 protein (lacking the C-terminal SOCS box) had an increased number of colony-forming cells upon exposure to G-CSF and IL-6. In an in vivo model of arthritis, truncation of SOCS3 leads to a more florid arthritis when compared with WT mice, suggesting that dysregulated PMN proliferation in the BM is associated with the development of autoimmune disorders. 8 During PMN differentiation, progenitor cells committed to hematopoietic lineages interact and migrate along and then across BM while receiving stimulatory and inhibitory signals from stromal marrow cells. It is known that constitutive expression of stromal-derived factor (SDF-1/CXCL12) and its G protein-coupled chemokine receptor (CXCR4) are required for hematopoietic cell adhesion, and PMN retention in the BM. 9 In contrast, release of PMN occurs through CXCL2
(MIP-2) interaction with its receptor CXCR2, or through G-CSFR or TLRs, all of which appear late during PMN maturation in the BM. 10 Consequently, mature PMN up-regulate expression of CXCR2 and decrease CXCR4 expression, a balance that favors release of BM PMN into the circulation. 11 CXCR2, is a chemokine receptor that has been shown to favor PMN release and as such, Cxcr2 −/− PMN fail to exit the BM, reproducing a myelokathexis phenotype. G-CSF decreases CXCL12 expression in the BM, decreases PMN CXCR4 expression and, induces BM expression of the CXCR2 ligand CXCL2, ultimately promoting PMN release into the circulation. 12 CXCR4 on the other hand, opposes the role of CXCR2. Therefore, mutations causing increased activation of CXCR4 result in increased PMN retention in the BM as seen in the human syndrome WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis). 13 Conversely, the deletion of CXCR4 in myeloid cells promotes a substantial neutrophilia. 14 Therefore, CXCL2-CXCR2 signaling represents a chemokine axis that controls PMN migration out of the BM by opposing CXCL12-CXCR4 signals. 11 PMN release may be also be mediated by signals through G-CSFR, formyl-methionyl-leucyl phenylalanine peptide (fMLF) receptors, or TLRs, but in the absence of CXCR4, the stimulation of these receptors does not cause additional PMN release from the BM, demonstrating the essential role of CXCR4 signaling for PMN retention in the BM. 14 The adhesion and retention of PMN precursors within the BM shown to act as a negative regulator of PMN functions and it is an important part of the regulatory network that links chemotactic signals to adhesive responses of hematopoietic cells. 15 Nakata et al. 16 showed that Lyn negatively regulates CXCL12-CXCR4-mediated PMN adhesion to BM. Activation of Lyn by CXCL12-CXCR4 inhibits activation of the 2 integrin LFA-1, reducing adhesion to intercellular adhesion molecule-1 (ICAM-1) and allowing PMN to move more freely within the marrow, where they continue their maturation before being released into the circulation. 16 In vitro assays showed that PMN deficient in Lyn express normal levels of integrins (including LFA-1), but demonstrate increased attachment to BM stromal cells and decreased migration in response to CXCL12. Most probably this transient Lyn-mediated inhibition of CXCR4-2 integrin activation occurs via inside-out signaling through as yet unidentified pathways.
This negative regulation is not solely activated by the CXCR4 receptor as fMLF-induced PMN chemotaxis also requires Lyn to inhibit 2 integrin-dependent cell adhesion to ICAM-1. 16 GPCRs involved in PMN proliferation and maturation in the BM are regulated by the activity of downstream kinases. As such, members of the GPCR kinase (GRK) and arrestin families induce GPCR desensitization upon agonist stimulation leading to a feedback mechanism that rapidly uncouples the receptor from its associated G protein. There are 7 GRKs known, with GRK2, -3, -5, and -6 being the 4 most widely expressed members. Studies from Grk6-deficient mice suggest GRK6
inhibits CXCL12-induced chemotaxis of PMN. 17, 18 Balabanian et al. 19 also described a pivotal role for GRK3 in CXCR4-mediated signaling through internalization and desensitization of CXCR4 in fibroblasts and T cells. CD4+ T cells from WHIM syndrome patients displayed a stronger chemotaxis in response to CXCL12. However, the role of GRK3 and GRK6 in regulating PMN mobilization from BM into blood in response to CXCL12-CXCR4 has not been fully characterized. Phosphorylation of intracellular ITIM domains by Src kinases leads to recruitment of SHP1/2 and SHIP1/2 followed by subsequent inhibition of Syk kinase-mediated PI3K activation, CD11b/CD18 signaling, actin polymerization, ERK1/2 activation, Rap activation and Ca 2+ mobilization, decreased generation of PtdIns(3,4,5)P3, and decreased Akt activation leading to reduced PMN activation and reduced PMN trafficking 16, [26] [27] [28] [29] [33] [34] [35] 42 In addition to negative regulation of PMN maturation by protein kinases, granulopoiesis is also suppressed by protein phosphatases.
Wild-type p53-induced phosphatase 1 (Wip1, also known as PP2Cd)
is an oncogene that inhibits several p53-dependent tumor suppressor pathways. Expression of Wip1 increases during PMN maturation and, Wip1-deficient mice display increased granulocytic differentiation, proliferation, and BM maturation leading to a severe neutrophilia, suggesting that Wip1 is a negative regulator of both granulopoiesis and PMN homeostasis. 20 Further, in response to G-CSF, BM PMN deficient in Wip1 displayed rapid and increased phosphorylation of p38 MAPK and STAT1 suggesting that Wip1 inhibits p38 MAPK/STAT1-mediated PMN maturation. 20 Another possible explanation for the neutrophilia observed in Wip1 −/− mice is that Wip1-deficient PMN express higher levels of CXCR2 and lower levels of CXCR4 than WT mice, thus favoring the release of PMN into the circulation. 11 
SIGNALING EVENTS THAT INHIBIT PMN TRAFFICKING TO SITES OF INFECTION/INFLAMMATION
PMN migration to inflamed mucosal tissues requires sequential migration across endothelial 21 (Fig. 1). 
SIRP receptors
Phagocytes, including PMN, express the ITIM containing protein sig- 
Src family tyrosine kinases and phosphatases signal downstream of ITIM domains
In addition to inhibitory signaling mechanisms orchestrated through phosphorylation of ITIM domains, protein phosphatases also counterbalance PMN signaling activation and play a central role in inhibiting PMN migration. Tyrosine phosphorylation is one of the earliest consequences of PMN cell surface receptor activation. 29 The Src family tyrosine kinases have been implicated in a number of GPCR signaling pathways that propagate downstream signals in a positive fashion resulting in activation of PMN processes including migration, phagocytosis, and degranulation. 30, 31 However, the role of Src kinases in PMN activation is somewhat controversial in that it has also been reported that Src kinases can also act as negative regulators of PMN function. PMN from double KO Hck/Fgr mice displayed significantly higher peak Ca 2+ flux following stimulation with chemokines including CCL3, CXCL1 and CXCL2, and IL-8. 27 In addition, double In keeping with its role as a negative regulator of immune cell function, Ptp1b KO mice exhibited higher accumulation of PMN (as measured by myeloperoxidase (MPO) levels and severity of edema) in the ear in response to LPS or Zymosan 35 and in the lungs in response to Pseudomonas aeruginosa. 36 Similarly, in a respiratory syncytial virus model of lung inflammation, loss of PTP1B expression resulted in changes in cytokine signaling, elevated PMN accumulation, and increased damage and disruption of the epithelial cell barrier. 37 allergen. 45 Binding of the glucocorticoid-regulated protein Annexin A1 (Anxa1) to its GPCR (formyl peptide receptor type 2/lipoxin A4 receptor, FPR2/ALX) has also been identified as a mechanism for limiting the scope of an inflammatory response. As such, administration of Anxa1 to mice results in potent inhibition of PMN egress from the microcirculation. 46 Corroborating evidence of the inhibitory role of Anxa1 was provided by in vitro studies demonstrating inhibition of PMN transmigration across endothelial cells upon treatment with Anax1. Consistent with these data, PMN from Anxa1-deficient mice have increased CD11b/CD18 surface expression and increased chemotactic responses compared with WT PMN. 47 Binding of the antiinflammatory ligand lipoxin A4 to FPR2/ALX also inhibits PMN chemotaxis, adhesion, and transmigration across vascular endothelium. 48 Further evidence for FPR2/ALX acting as an anti-inflammatory GPCR was provided using mice lacking FPR2/ALX. These mice had increased inflammation associated with a marked increase in PMN adherence and emigration in the mesenteric microcirculation following ischemia reperfusion injury and as well as an increased acute response to carrageenan-induced paw edema compared with WT FPR2/ALX expressing PMN. 49 Given the number of studies demonstrating that PMN FRP2/ALX can be targeted to negatively regulate PMN trafficking and PMN inflammatory function, signaling through this GPCR is an area that is currently being investigated for anti-inflammatory therapeutics. 50 phagocytosis were also reported in primary macrophages. 57 These phenotypes suggest a potential role for both of these Rac GAPs in down regulating PMN phagocytosis in order to promote pathogen clearance while minimizing PMN-inflicted tissue damage (Fig. 2) .
Immune signaling through small GTPases regulates PMN trafficking

Immune signaling by JAK-STAT regulates PMN trafficking
In addition to F-actin-mediated regulation of phagocytosis, suppression of phagocytosis downstream of phosphatase activity has also been reported. PTEN is a phosphatase that negatively regulates PtdIns(3,4,5)P3 therefore acting as a negative regulator of several PMN effector functions including phagocytosis. Li and colleagues 43 reported that PTEN null PMN showed enhanced bacteria killing in a pneumonia model due to increased phagocytic capacity. Another phosphatase, the ubiquitous tyrosine phosphatase PTP1B has been shown to negatively regulate PMN function. In a P. aeruginosa infection model, Ptp1b −/− mice displayed enhanced bacterial clearance accompanied by increased PMN infiltration in the lungs, suggesting increased phagocytosis in the absence of PTP1B. 36 However, further analysis dissecting the individual roles of PMN and macrophages in bacterial clearance is necessary in order to conclude PTP1B negatively regulates PMN phagocytosis.
Release of anti-inflammatory cytokines during later stages of an immune response also serves to dampen PMN activation and prevent detrimental damage to host tissues. Recently Gough et al. 53 
SMALL GTPASE-MEDIATED REGULATION OF PMN REACTIVE OXYGEN SPECIES PRODUCTION
Following migration into inflamed tissues and phagocytosis, PMN destroy engulfed pathogens in part through the generation of an oxidative burst (reviewed in full elsewhere 58 60 Bcr is another Rac1/Rac2 GAP implicated in signaling events that down-regulate PMN ROS production and it has been reported that PMN from Bcr −/− mice have increased Rac-mediated reactive oxygen metabolite production in response to fMLF. 61 Arap3 is a PI3K-regulated RhoA GAP that also signals to down-regulate PMN activation. In keeping with this, an increase in 2 integrin/adhesion-dependent ROS generation in PMN deficient in Arap3 has been reported. 62 Finally, enhanced ROS generation associated with augmented translocation of the gp91 phox -p22 phox complex, the phagocyte oxidase component p47 phox and the atypical protein kinase C to the plasma membrane has been reported in RhoA/Bdeficient PMN, further demonstrating the suppressive role of small GTPases on generation of the PMN superoxide burst 38 (Fig. 2) . GTPase-activating proteins (GAPS) have been shown to suppress PMN functions such as phagocytosis, ROS production, and degranulation by inhibiting the activation of Rac and F-actin polymerization. 39, 40, 56, 57, 61 Vav-1 and TIPE-2 also inhibits Rac activation and therefore, suppress ROS production. 59, 60 Phosphatases such as PTP1B and PTEN negatively regulates phagocytosis. 36 PTEN also regulates ROS production by regulating the availability of PtdIns(3,4,5)P3. 41 Because it is well described that NET formation depends of ROS production, it is possible that negative regulators of ROS production are also potentially inhibiting NETosis. C-terminal kinase inhibits degranulation by phosphorylating the C-terminal inhibitory tyrosine residues of Src kinases. 69 PMN apoptosis can be delayed by active Akt promoting the inactivation of caspase-9 and therefore the inactivation of the pro-apoptotic Bcl-2 family member Bax. In addition, Akt has been described to inactivate GSK3 , preventing the degradation of the anti-apoptotic Bcl-2 member Mcl-1 72
ITIM containing immunoreceptors regulate PMN ROS generation
Similar to other important PMN effector functions (discussed above), PMN ROS production is also subject to negative regulation by ITIM- 
NEGATIVE IMMUNE REGULATORS OF PMN APOPTOSIS
To achieve and maintain homeostasis, circulating PMN die via constitutive apoptosis and are cleared by macrophages in the liver, spleen, and BM. Given the short half-life of PMN, suppression of apoptosis is also essential to facilitate the extended PMN life span observed in the tissues during infection/inflammation. Several agents that prime or activate human PMN including, cytokines, GM-CSF, C5a, LPS, inositol hexakisphosphate, and LTB 4 are also reported to prolong PMN survival and down-regulate apoptosis. 71 In particular, PI3K/Akt signaling plays a pivotal role in PMN survival/suppression of apoptosis. Akt-mediated phosphorylation inactivates caspase-9 and stops the pro-apoptotic Bcl-2 family member Bax from associating with mitochondria. 72 In addition, inactivation of the Akt target GSK3 prevents phosphorylation, ubiquitination, and proteosomal degradation of the pro-survival Bcl-2 family member Mcl-1 (Fig. 2) . 72 Mechanistically, it has been reported that in apoptotic PMN, accumulated ROS inhibits actinmediated-PI3K -dependent PtdIns(3,4,5)P3 generation, thus blocking Akt activation and allowing apoptosis to proceed. 73 Proliferating cell nuclear antigen also functions as a PMN anti-apoptotic mediator that binds constitutively to pro-caspases-3, -8, and -9 and blocks their proteolytic processing and activation. 74 Elevated levels of the second messenger cyclic AMP can also prolong PMN life span by delaying apoptosis. Though the exact mechanism behind this has yet to be fully elucidated, it has been reported that increased intracellular cAMP levels delay PMN apoptosis via a transcriptionally independent pathway, independent of PI3K activity that involves inhibition of caspase 3 activation and a loss in mitochondrial potential. Another signaling mechanism employed by PMN to delay apoptosis is augmenting production of the second messenger PtdIns(3,4,5)P3 and thus, increasing Akt activation. As such, depleting PTEN increases PtdIns(3,4,5)P3 levels, dramatically delays spontaneous apoptosis of PMN in vitro, 75 and reduces apoptosis of PMN in inflamed alveolar air spaces. 43 The Src family kinase member Lyn is also an important tyrosine kinase for transducing anti-apoptotic signaling in PMN. 76 ITIM-mediated signaling also regulates PMN apoptosis. In particular, binding of CD47
to SIRP induces ITIM phosphorylation and recruitment of SHP-1 and SHP-2 ultimately resulting in the inhibition of PMN apoptosis. 77 As such, increased PMN surface expression of CD47 is associated with a delay in apoptosis and poor prognosis in non-small cell lung cancer patients. 78 Finally, recent studies have demonstrated that sialylated erythrocyte surface glycans engage the inhibitory immunoreceptor Siglec 9 on circulating PMN to suppress activation and apoptosis. 65 
INHIBITION OF PMN NET RELEASE
Neutrophil extracellular trap (NET) release represents an additional PMN extracellular antimicrobial function that can also lead to an alternative form of PMN cell death (NETosis) that is distinct from necrosis or apoptosis. Negative regulation aimed at dampening NET formation remains largely unstudied despite recognition of the contribution of NETs to vascular damage and autoimmunity. 79, 80 However, it would be logical to think that ITIM-mediated negative regulation of NADPH-dependent ROS production and degranulation of primary granules would also suppress NET formation (Fig. 2) for SIRL-1 are yet to be identified, cross-linking of SIRL-1 has been shown to dampen MEK-ERK signaling and suppress spontaneous NET release in PMN from individuals with systemic lupus erythematosus (SLE). 81 Moreover, ligation of SIRL-1 also reduces NET formation in PMN from control donors when incubated with plasma from SLE patients. 81 In addition, NET formation induced by opsonized S.
aureus and monosodium urate is suppressed by SIRL-1. 82 In contrast, cross-linking of SIRL-1 does not reduce NET formation when human PMN were exposed to non-opsonized S. aureus or to the TLR4 agonist LPS, indicating SIRL-1 regulates NET formation only in response to specific signals. Importantly, phagocytosis and ROS production remain intact following crosslinking of SIRL-1. Therefore, SIRL-1 specifically regulates cellular pathways required for extracellular NET formation, but not intracellular microbial killing. 82 The ITIM containing immunoreceptors Siglec 9 and Siglec 5 also deliver inhibitory signals that dampen NET formation by human PMN.
As discussed above, PMN activation in the circulation is suppressed by erythrocyte sialoglycoproteins interacting with Siglec 9. 65 In addition, increased concentrations of erythrocytes significantly reduced extracellular DNA release by PMN in response to PMA. Further, this effect was lost when the side chains of the terminal sialic acids were selectively and specifically modified to reduce erythrocyte binding to Interestingly, some human pathogens, including Group A (GAS) and Group B (GBS) Streptococcus, interact with PMN Siglecs through their capsular polysaccharide components to down-regulate PMN activation and increase the rate of bacterial survival. [84] [85] [86] [87] GAS expresses a HMW-HA capsule and GBS displays terminal sialic acids, both of which are able to engage Siglec 9 and block NET formation. 84, 86 GBS also binds to Siglec 5 through protein expressed in its capsule, resulting in inhibition of NET formation independent of sialic acid binding. 85 P. aeruginosa, an opportunistic human pathogen, does not synthetize sialic acid but it is able to absorb sialoglycoproteins from host serum that it uses to bind to PMN Siglec 9 thus suppressing PMN ROS release and NET formation. 87 Another family of proteins that play multiple roles in regulating PMN effector functions is the semaphorins. Semaphorins are transmembrane proteins that bind several receptors, that is, plexins B1/B2 and CD72. 88 Recently, it has been reported that binding 
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